Organon & Co | OGN - Despesas De Vendas E Administração





Despesas De Vendas E Administração Alterar Data
Bristol-Myers Squibb USD 2.18B 392M 2025-12
Celltrion KRW 249.98B 16.36B 2025-09
Cspc Pharmaceutical CNY 1.97B 404.66M 2025-09
Deva Holding AS TRY 462.26M 48.18M 2023-09
Dianthus Therapeutics USD 8.2M 669K 2025-09
Divis Laboratories Ltd INR 3.4B 10M 2025-06
Gilead Sciences USD 1.78B 425M 2025-12
Glaxosmithkline GBP 2.91B 817.89M 2025-09
Kangmei Pharma CNY 274.41M 15.05M 2025-09
Knight Therapeutics CAD 31.02M 464K 2025-09
Laboratorios Farma EUR 35.32M 2.75M 2025-06
Malin Corporation EUR 1.1M 400K 2024-12
Medical Developments International AUD 2.84M 4.19M 2025-12
Merck USD 2.85B 215M 2025-12
Neuren Pharmaceuticals AUD 3.74M 2.5M 2025-12
Novartis USD 3.3B 137M 2025-09
Organigram Holdings CAD 8.86M 499K 2025-09
Organon & Co USD 399M 54M 2025-09
Ovoca Bio EUR 2.96M 8K 2022-06
Pharma Mar EUR 17.31M 3.6M 2025-12
Qiagen NV USD 153.88M 10.77M 2025-12
Sartorius EUR 218.7M 6.5M 2025-09
Sino Biopharmaceutical CNY 7.54B 2.23B 2025-06
Tilray USD 24.85M 1.7M 2025-09